ANZTPA update
12 March 2007
This email was sent to ANZTPA-UPDATE email list subscribers on 12 March 2007.
Dear Sir/Madam
Recent updates to the Australia New Zealand Therapeutic Products Authority (ANZTPA) Project website are listed below:
- A guidance tool for assessing the appropriate regulatory coverage for products at the food-medicine interface <http://www.anztpa.org/meds/gt-food-medicine.htm>. This guidance tool is intended to be used to determine whether a product that falls within the 'grey-area' at the food-medicine interface would be regulated as a food or as a therapeutic product.
- Questions and answers (Q&As) raised during the consultation workshops on the proposed regulation of blood, proposed arrangements for product vigilance and proposed medicines scheduling provisions. To access these Q&As click on the link(s) below:
- Questions and answers about the proposed regulation of blood <http://www.anztpa.org/bt/qablood.htm>
- Questions and answers about the proposed arrangements for product vigilance <http://www.anztpa.org/safety/qavigilance.htm>
- Questions and answers about the proposed medicines scheduling provisions <http://www.anztpa.org/meds/qascheduling.htm>
- Minutes from the second meeting of the Advertising Implementation Steering Group <http://www.anztpa.org/advert/aisg.htm#minutes>
Note: The project team would also like to remind stakeholders that submissions on the draft Advertising Rule <http://www.anztpa.org/consult/consdocs2a.htm> close this week (Wednesday 14 March 2007).
URL: http://www.anztpa.org/new/anztpa-update/2007/070312update.htm